Complex Malignancies: A Diagnostic and Therapeutic Trilemma.

Fed Pract

Ms. is an acute care nurse practitioner, is the director of the Interprofessional Fellowship program in patient safety, and is the program leader of pathology and laboratory medicine, and all authors are affiliated with the Lung Cancer Collaborative, all at the Pittsburgh VA Healthcare System in Pennsylvania. Dr. Eibling is also a professor of otolaryngology and vice chair for education at the University of Pittsburgh.

Published: September 2015

A patient presented with esophageal adenocarcinoma, pulmonary small-cell carcinoma, and high-grade carcinoma, which is a rare occurrence that required a staged multidisciplinary approach to treatment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364825PMC

Publication Analysis

Top Keywords

complex malignancies
4
malignancies diagnostic
4
diagnostic therapeutic
4
therapeutic trilemma
4
trilemma patient
4
patient presented
4
presented esophageal
4
esophageal adenocarcinoma
4
adenocarcinoma pulmonary
4
pulmonary small-cell
4

Similar Publications

Intra-abdominal lymphangioma, a rare benign lymphatic malformation resulting from an obstruction to lymphatic channels, often has non-specific clinical manifestations. Low incidence rates of this condition, paired with its unusual presentation and ambiguous radiological appearance, commonly lead to diagnostic uncertainty. This pathology can result in significant morbidity and mortality, emphasising the need to achieve early diagnosis and management despite these challenges.

View Article and Find Full Text PDF

Iron-Based Nanomaterials for Modulating Tumor Microenvironment.

Wiley Interdiscip Rev Nanomed Nanobiotechnol

January 2025

Laboratory of Advanced Theranostic Materials and Technology, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, China.

Iron-based nanomaterials (IBNMs) have been widely applied in biomedicine applications including magnetic resonance imaging, targeted drug delivery, tumor therapy, and so forth, due to their unique magnetism, excellent biocompatibility, and diverse modalities. Further research on its enormous biomedical potential is still ongoing, and its new features are constantly being tapped and demonstrated. Among them, various types of IBNMs have demonstrated significant cancer therapy capabilities by regulating the tumor microenvironment (TME).

View Article and Find Full Text PDF

Colorectal cancer (CRC) is a histologically heterogeneous disease with variable clinical outcome. The role the tumour microenvironment (TME) plays in determining tumour progression is complex and not fully understood. To improve our understanding, it is critical that the TME is studied systematically within clinically annotated patient cohorts with long-term follow-up.

View Article and Find Full Text PDF

Spatial omics shed light on the tumour organisation of glioblastoma.

Semin Cell Dev Biol

January 2025

Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia; Department of Medical Biology, University of Melbourne, Melbourne, Australia. Electronic address:

The glioblastoma tumour microenvironment is characterised by immense heterogeneity, with malignant and non-malignant cells that interact in a complex ecosystem. Emerging evidence suggests that the tumour microenvironment is key in facilitating rapid proliferation, invasion, migration and cancer cell survival, crucial for treatment resistance. Spatial omics technologies have enabled the molecular characterisation of regions or individual cells within their spatial context, providing previously unattainable insights into the complex organisation of the glioblastoma tumour microenvironment.

View Article and Find Full Text PDF

[Initial experience of minimally invasive liver resection at a reference center in Mexico].

Cir Cir

January 2025

Departamento de Cirugía Hepatopancreatobiliar, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, México.

Objective: Minimally invasive liver resection is employed worldwide for the management of benign and malignant liver lesions. There is no description of postoperative outcomes in the Mexican population. This study aims to report the initial experience in Mexico.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!